Voyager Therapeutics Inc
NASDAQ:VYGR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Voyager Therapeutics Inc
Voyager Therapeutics Inc
Total Current Assets
Voyager Therapeutics Inc
Total Current Assets Peer Comparison
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Voyager Therapeutics Inc
NASDAQ:VYGR
|
Total Current Assets
$409.1m
|
CAGR 3-Years
33%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Current Assets
$38.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
8%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Current Assets
$14B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Current Assets
$28B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Current Assets
$13.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
25%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Current Assets
$18.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Voyager Therapeutics Inc's Total Current Assets?
Total Current Assets
409.1m
USD
Based on the financial report for Mar 31, 2024, Voyager Therapeutics Inc's Total Current Assets amounts to 409.1m USD.
What is Voyager Therapeutics Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
2%
Over the last year, the Total Current Assets growth was 35%. The average annual Total Current Assets growth rates for Voyager Therapeutics Inc have been 33% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
